ArticleJAMIA open2026
Multivariate time-series forecasting of liver biomarkers from longitudinal lifestyle data for nonalcoholic steatohepatitis detection.
Article in JAMIA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To develop a machine learning method that estimates future liver biomarkers' values from longitudinal lifestyle (diet, activity) data for early detection of nonalcoholic steatohepatitis (NASH). Materials and Methods: The method in this study is developed utilizing the nonalcoholic fatty liver disease adult dataset, by National Institute of Diabetes and Digestive and Kidney Diseases, a real-world dataset representative of common electronic health records in the United States. We have developed time-series Machine Learning/Deep Learning and tree-based models to forecast future values for liver biomarkers, identified the minimum requirement of initial data points for optimal forecasting performance, and developed time-series classifier models for detecting NASH from longitudinal lifestyle data and initial biomarker values. Results: Our experiments show that lifestyle-informed forecasting models, such as Attention-long short-term memory and TimeSeriesForestRegressor accurately predict future biomarker trajectories with as few as 2 observed timepoints (prediction error as low as 0.62), and NASH classifiers trained on these Discussion: The proposed approach, Conclusion: Lifestyle-driven biomarker forecasting offers a promising, minimally invasive foundation for early NASH detection and long-term disease management, reducing dependence on frequent laboratory testing and biopsy-aligned measurements.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.